We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167 → 175 (+8)

4% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 57

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
59
Reduced
57
Closed
18
Calls
$7.01M
Puts
$40.8M
Net Calls
-$33.8M
Net Calls Change
-$26.8M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$14.3M
2
BFA
BlackRock Fund Advisors
California
+$12.4M
3
SCM
Scopia Capital Management
New York
+$6.5M
4
SM
Sabby Management
Florida
+$5.23M
5
Millennium Management
Millennium Management
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$13.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.44M
4
Goldman Sachs
Goldman Sachs
New York
-$7.54M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$7.06M +$2.02M +848 +37%
Two Sigma Investments
27
Two Sigma Investments
New York
$6.61M +$2.32M +974 +50%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$6.56M +$1.19M +500 +21%
Goldman Sachs
29
Goldman Sachs
New York
$6.47M -$7.54M -3,170 -52%
Principal Financial Group
30
Principal Financial Group
Iowa
$6.38M +$107K +45 +2%
SIM
31
Spark Investment Management
New York
$6.16M +$704K +296 +12%
Public Employees Retirement Association of Colorado
32
Public Employees Retirement Association of Colorado
Colorado
$6M – – –
JP Morgan Chase
33
JP Morgan Chase
New York
$5.43M -$183K -77 -3%
Ameriprise
34
Ameriprise
Minnesota
$5.19M +$52.3K +22 +1%
SM
35
Sabby Management
Florida
$4.96M +$5.23M +2,200 New
OAM
36
Oxford Asset Management
United Kingdom
$4.73M -$2.64M -1,111 -35%
TA
37
Teachers Advisors
New York
$4.71M +$40.4K +17 +0.8%
BIM
38
BlackRock Investment Management
Delaware
$4.43M +$815K +343 +21%
Stifel Financial
39
Stifel Financial
Missouri
$4.11M +$300K +126 +7%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$4.09M +$3.11M +1,307 +257%
Skandinaviska Enskilda Banken (SEB)
41
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.72M – – –
Deutsche Bank
42
Deutsche Bank
Germany
$3.61M +$1.02M +427 +36%
Citigroup
43
Citigroup
New York
$3.36M +$2.71M +1,139 +326%
SO
44
STRS Ohio
Ohio
$3.08M – – –
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$2.99M +$1.51M +637 +114%
GAM
46
Gotham Asset Management
New York
$2.97M +$1.45M +609 +86%
TCIM
47
TIAA CREF Investment Management
New York
$2.86M -$152K -64 -5%
Bank of America
48
Bank of America
North Carolina
$2.79M -$376K -158 -11%
PAMU
49
Pictet Asset Management (UK)
United Kingdom
$2.75M -$3.87M -1,627 -57%
CS
50
Credit Suisse
Switzerland
$2.63M +$823K +346 +42%
1
2
3 4 5

ACOR Hedge Fund Activity: Q4 2016 in Review

175 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2016, worth a combined $899M — down 11% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 18 closed out — a net gain of 10 holders — while 59 added to existing stakes and 57 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $14.3M. The largest seller was Eagle Asset Management, cutting an estimated $13.7M.

  • 175 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2016, up from 167 in Q3 2016.
  • Funds reported $899M of Acorda Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2016 and 18 closed out, a net change of +10 holders.
  • The largest Acorda Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $14.3M added.
  • The largest Acorda Therapeutics seller in Q4 2016 was Eagle Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2016.